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CASE REPORT
Small colony variant of methicillin-resistant Staphylococcus aureus isolated 
from an osteomyelitis case
Server Yagci, Sukriye Kurkcuoglu, Barıs Dogan Ozturk, Fatma Sebnem Erdinc, Necla Eren Tulek
Infectious Diseases and Clinical Microbiology Clinic, Ankara Training and Research Hospital, Ankara, Turkey
ABSTRACT
Methicillin-resistant Staphylococcus aureus small colony variants may cause soft tissue infections. However, any case 
presenting with soft tissue abscess after a fracture surgery is not been reported yet. In this report; a case of methicillin-
resistant S. aureus small colony variant that was isolated from a 68-years-old man who has a fracture surgery history and 
recurrent abscess developing in his left thigh was reported. This variant was recovered from aspiration material of the 
open wound. Daptomycin was used successfully in the treatment of the bacterial infection which is resistant to rifampin. 
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Osteomyelit olgusundan izole edilen metisiline dirençli Staphylococcus aureus küçük 
koloni varyantı
ÖZET
Metisiline dirençli Staphylococcus aureus’un küçük koloni varyantları yumuşak doku enfeksiyonlarına sebep olabilmek-
tedir. Ancak kırık ameliyatı sonrası yumuşak doku apsesi ile seyreden bir olgu henüz rapor edilmemiştir. Bu yazıda; kırık 
öyküsü olan 68 yaşındaki erkek hastanın sol bacağında gelişen ve tekrarlayan apseden izole edilen metisiline dirençli S. 
aureus küçük koloni varyantı olgusu sunulmuştur. Bu varyant açık yaradan alınan aspirasyon materyalinden elde edildi. 
Rifampine dirençli olan bakteri enfeksiyonunun tedavisinde daptomisin başarıyla kullanıldı.
Anahtar klimeler: Küçük koloni varyantı, metisiline dirençli Staphylococcus aureus, tekrarlayan abse
INTRODUCTION
Small colony variants (SCVs) of S. aureus are iso-
lated in patients with persistent and recurrent infec-
tions such as osteomyelitis, septic arthritis, deep-
seated abscesses and respiratory tract infections in 
patients with cystic fibrosis.1-4 Small colony variants 
(SCVs) of S. aureus are known as slow growing 
subpopulations that form small, nonpigmented and 
non-hemolytic  colonies.  Deficiencies  in  electron 
transport activities leading to auxotrophism for thy-
midine, menadione, or hemin cause the typical bio-
chemical characteristics of the variants.5 By routine 
microbiological methods, these phenotypic variants 
of S. aureus may be misidentified, and they may 
also respond poorly to some antimicrobial agents.6 
Their isolation and identification remains difficult un-
less appropriate techniques are used in clinical mi-
crobiology laboratories. This problem might lead to 
diagnostic underestimation, which will cause thera-
peutic failures, in the clinical settings.
Methicillin-resistant S. aureus infections cause 
higher mortality and morbidity rates especially in 
intensive care patients. MRSA SCVs are reported 
to cause more severe infections and mortality rates 
than those caused by MRSA.7 However, there are 
only few case reports of MRSA SCVs in the litera-
ture. Here, we describe the first case of a soft tissue 
abscess caused by MRSA SCV, which occurred af-
ter femoral fracture surgery.
CASE REPORT
A 68-year-old man was admitted to the hospital with 
pain and erythema on his left leg in 29th November 
2011. He had been operated for femoral fracture in 
1995 and he developed abscess formation 3 years 
later. He had recurrent abscess formation at inter-Yagci S, et al. MRSA SCV in osteomyelitis 90
J Microbiol Infect Dis   www.jmidonline.org   Vol 3, No 2, June 2013
vals of several years thereafter. On his last admis-
sion to orthopedics outpatient department, he had 
used ciprofloxacin and fusidic acid for 8 days follow-
ing  one-week  amoxicillin-clavulanic  acid  per  oral. 
As his complaints had not been resolved, he had 
applied to another hospital and MRSA, which was 
resistant to gentamicin, rifampin and TMP-SXT, was 
isolated from his abscess culture. Then he referred 
to the infectious diseases clinic and hospitalized for 
his abscess. His medical history included diabetes 
mellitus for 25 years and hypertension for 10 years. 
He had also benign prostate hypertrophy and unilat-
erally nephrectomised for nephrolithiasis.
On admission, the patient was cooperated and 
oriented.  On  physical  examination,  a  5x5  cm  ul-
cerated wound with purulent discharge containing 
necrotic areas in patches was observed on lateral 
region of his left thigh. His vital signs and the re-
maining systems were normal on examination. His 
peripheral blood leukocyte count was 10.40x109/L, 
C reactive protein 18.8 mg/dl (normal <0.5 mg/dl), 
and the ESR was 57 mm/hour. Hyperglycemia and 
slightly increased creatinin levels were found. On 
superficial USG, there were two loculated collec-
tions compatible with the thick-walled abscess for-
mation. The first one was 6.5x2 cm subcutaneous 
along the superficial muscle groups, and the other 
was 4.5 x 1.5 cm deep in the posterior region. Al-
though there was bone marrow edema on magnetic 
resonance imaging (MRI) osteomyelitis was not re-
ported by radiology. Drainage of abscess was not 
indicated by orthopedicians at that time. The culture 
of pus aspirate was taken from the wound after skin 
was decontaminated. Subsequently, treatment with 
intravenous daptomycin (1 x 350 mg) was initiated.
Wound culture yielded non-pigmented, non-
hemolytic small colonies on 5% sheep-blood agar 
plates  (Figure  1).  Gram  positive  cocci  were  ob-
served. Catalase reaction and tube coagulase re-
sults were positive. Colonies were suspected to be 
S. aureus SCVs. Isolates were inoculated onto man-
nitol salt agar (MSA) (Becton, Dickinson and Com-
pany, USA), and mannitol positive yellow colonies 
were observed after incubation at 35°C overnight 
(Figure  1).  These  colonies  were  inoculated  onto 
sheep  blood  agar  and  Schaedler  agar  (ORBAK, 
Ankara, Turkey) simultaneously. Sheep blood agar 
was incubated in normal atmosphere and Schaedler 
agar in 5-10% CO2, both at 35°C. The small, non-
pigmented, non-hemolytic colonies on sheep blood 
agar were observed as normal sized, hemolytic and 
pigmented on Schaedler agar, and they are consid-
ered as S. aureus SCVs. Antimicrobial susceptibility 
testing was performed by broth microdilution method 
according to CLSI guidelines.8 The isolate identified 
as MRSA SCV was resistant to penicillin, ampicil-
lin, ampicillin-sulbactam, amoxicillin-clavulanic acid, 
oxacillin, cefoxitin, tetracycline, and rifampin; inter-
mediate for ciprofloxacin; susceptible to gentamicin, 
imipenem, moxifloxacin, erythromycin, clindamycin, 
trimetoprim-sulphametoxazole, vancomycin, teico-
planin, linezolid, and tigecycline.
Figure 1. Nonpigmented, non-hemolytic, small colonies suspected as S. aureus SCVs on blood agar plates (A), and 
on mannitol salt agar (MSA) as mannitol positive after subculturing (B)
After re-evaluation of wound region, drainage 
was performed by orthopedics on the 21st day of 
treatment and there was no growth on cultures of 
aspiration material. Wound care including debride-
ment and daily dressing were performed by ortho-
pedics. There was bone marrow edema on MRI and 
recurrent abscess in his history; so osteomyelitis 
could not be excluded. Consequently scintigraphic Yagci S, et al. MRSA SCV in osteomyelitis 91
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imaging findings supported ostemyelitis and there-
fore osteomyelitis treatment was administered to 
the patient. Daptomycin was stopped on the 60th 
day of treatment. The patient was recovered, and 
he was discharged.
DISCUSSION
To our knowledge, this is the first report of soft tissue 
abscess caused by small colony variant of MRSA in 
a patient with recurrent abscess history after frac-
ture  surgery.  However,  MRSA  SCV  was  isolated 
only in the last episode. There are only few case re-
ports of MRSA SCVs in the literature. The first fatal 
case due to MRSA SCVs was an AIDS patient and 
the isolate has been recovered from blood cultures 
and abscess samples after long-term prophylaxis of 
TMP-SXT for Pneumocystis jirovecii pneumonia.9 In 
other two reports MRSA SCVs was identified as the 
cause of recurrent ventriculoperitoneal shunt–re-
lated meningitis and brain abscess respectively.6,10 
Proctor et al described a case of septic arthritis aris-
ing from hip prosthesis that blood cultures revealed 
MRSA SCVs and persisted for 38 days.7
S. aureus SCVs have the ability of persisting 
under  antibiotic  pressure.  Exposure  to  different 
classes of antibiotics may cause the selection of 
these variants both in vitro and in vivo, and the diag-
nosis and treatment becomes difficult consequent-
ly.11 S. aureus SCVs may also have decreased sus-
ceptibility to cell-wall-active antibiotics.7 In this case, 
unfortunately, the antibiotic treatment history of the 
patient during previous abscess formations was un-
available. Amoxicillin-clavulanic acid was used by 
orthopedics in the last episode but, abscess forma-
tion was not resolved.
S. aureus SCVs may be protected from host 
defenses and the effect of antibiotics as they could 
persist  intracellularly.  Therefore,  antimicrobial 
agents such as rifampin having intracellular activity 
should be used in the treatment of S. aureus SCV 
infections.10 It was shown in a tissue culture system 
that rifampin combined with TMP-SXT was the most 
active therapeutic regimen, but more research is 
necessary to clarify the optimal treatment for infec-
tions caused by S. aureus SCVs.12 A combination of 
rifampin and a fluoroquinolone was also proposed, 
but it was not adequate for MRSA which are often 
resistant to fluoroquinolones.13,14 Vancomycin must 
be added to the regimen if SCV is a MRSA.15 Thus, 
treatment with a combination vancomycin and ri-
fampin which has been shown to be intracellularly 
active is a proper regimen for MRSA SCV. In this 
patient,  S. aureus SCV was methicillin resistant 
and also resistant to some other antibiotics includ-
ing rifampin. Creatinine levels were increased in the 
patient thus, vancomycin was not used, and treat-
ment was carried out with intravenous daptomycin 
for 60 days. Daptomycin was reported to be a po-
tential therapeutic option for infections caused by S. 
aureus SCVs in some experimental studies.6-19 Also 
prolonged high doses of daptomycin have been 
used for a prosthesis joint infection caused by S. 
aureus SCV and the patient have been treated suc-
cessfully.20 However additional clinical studies are 
needed for the antimicrobial activity of daptomycin 
against S. aureus SCVs.
In case of samples sent from patients who re-
ceived antibiotic treatment for a long period, clinical 
microbiology laboratories should be on alert of S. 
aureus SCVs, and proper methods should be used 
to detect SCVs. When there is an infection resistant 
to treatment, persistent or not respond to proper an-
timicrobial therapy S. aureus SCVs should be con-
sidered. In these situations, clinicians should ask 
the clinical microbiology laboratory to search for S 
aureus SCVs. Identification of MRSA SCVs might 
have an impact on the selection of treatment regi-
mens as MRSA SCVs tend to resist intracellular kill-
ing and are more resistant to antibiotics.
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